AMANDA MASTROFINI: Open Payments
NPI 1285118919 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 6 payments from 3 companies in 2025. Trend: 2023 $23 · 2024 $472 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 1 | $129 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Ipsen Biopharmaceuticals, Inc | 4 | $91 |
Products named: MYRISK, Onivyde.
Industry payments across MI — which companies pay providers there.
